Cancer Research Foundation Announces New Board Member

Share Article

The Mesothelioma Applied Research Foundation (Meso Foundation) announced today that Melissa Culligan, RN, BSN, MS, a thoracic surgery nurse with extensive mesothelioma experience, has joined the organization’s Board of Directors.

Mesothelioma Applied Research Foundation Logo
The Mesothelioma Applied Research Foundation announced that starting on October 24, Melissa Culligan, RN, BSN, MS, a thoracic surgery nurse with extensive mesothelioma experience, has joined its Board of Directors.

The Mesothelioma Applied Research Foundation announced that starting on October 24, Melissa Culligan, RN, BSN, MS, a thoracic surgery nurse with extensive mesothelioma experience, has joined its Board of Directors.

Ms. Culligan has worked as a thoracic surgery nurse for over 25 years and has worked in the field of thoracic oncology research for the past 15 years. She currently works in the Division of Thoracic Surgery at Penn-Presbyterian Medical Center and is the Director of Clinical Services for the Penn Mesothelioma and Pleural Program. She has a special interest in the areas of mesothelioma and advanced stage lung cancer and has recently graduated from Drexel University’s School of Medicine’s Master’s Program in Clinical Research Organization and Management.

Ms. Culligan has presented at the Meso Foundation’s International Symposium on Malignant Mesothelioma several times, and has participated in the organization’s Meet the Experts interview series. The podcast of her interview is available at http://blog.curemeso.org/tag/melissa-culligan-upenn/

Members of the Meso Foundation’s Board of Directors assume responsibility for ensuring the organization’s long-term financial stability and integrity and – through consensus and majority vote with the other Board members – for governing the Foundation and setting its strategic direction and broad policy directives.

Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. Medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the Navy or working in shipyards.

ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION
The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund peer-reviewed mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer reviewed scientific research to establish effective treatments for mesothelioma and, ultimately, a cure for this extremely aggressive cancer. To date, the Foundation has awarded over $8.7 million to research. More information is available at http://www.curemeso.org.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Maja Belamaric
Mesothelioma Applied Research Foundation
Like >
Follow us on
Visit website